Outcomes of Extracorporeal Life Support (ECLS) in Acute Severe Asthma: A Narrative Review

Abstract

BackgroundIn this narrative review we aimed to explore outcomes of extracorporeal life support (extracorporeal membrane oxygenation (ECMO) and extracorporeal carbon dioxide removal (ECCO2R)) as rescue therapy in patients with status asthmaticus requiring mechanical ventilation.MethodsMultiple databases were searched for studies fulfilling inclusion criteria. Articles reporting mortality and complications of ECMO and ECCO2R in mechanically ventilated patients with acute severe asthma (ASA) were included. Pooled estimates of mortality and complications were obtained by fitting Poisson’s normal modeling.ResultsSix retrospective studies fulfilled inclusion criteria thus yielding a pooled mortality rate of 17% (13–20%), pooled risk of bleeding of 22% (7–37%), mechanical complications in 26% (21–31%), infection in 8% (0–21%) and pneumothorax rate 4% (2–6%).ConclusionOur review identified a variation between institutions in the initiation of ECMO and ECCO2R in patients with status asthmaticus and discrepancy in the severity of illness at the time of cannulation. Despite that, mortality in these studies was relatively low with some studies reporting no mortality which could be attributed to selection bias. While ECMO and ECCO2R use in severe asthma patients is associated with complication risks, further studies exploring the use of ECMO and ECCO2R with mechanical ventilation are required to identify patients with favorable risk benefit ratio.